HIGH-DOSE ALKYLATING AGENT CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW SUPPORT IN PATIENTS WITH STAGE-III/IV EPITHELIAL OVARIAN-CANCER

被引：55

作者：

SHPALL, EJ ^{[1
]}

CLARKEPEARSON, D ^{[1
]}

SOPER, JT ^{[1
]}

BERCHUCK, A ^{[1
]}

JONES, RB ^{[1
]}

BAST, RC ^{[1
]}

ROSS, M ^{[1
]}

LIDOR, Y ^{[1
]}

VANACEK, K ^{[1
]}

TYLER, T ^{[1
]}

PETERS, WP ^{[1
]}

机构：

[1] DUKE UNIV, MED CTR, DUKE COMPREHENS CANC CTR, DURHAM, NC 27710 USA

来源：

GYNECOLOGIC ONCOLOGY | 1990年 / 38卷 / 03期

关键词：

D O I：

10.1016/0090-8258(90)90079-Z

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：386 / 391

页数：6

共 32 条

[11]

DEDRICK RL, 1978, CANCER TREAT REP, V62, P1

[12] ADVANCED OVARIAN-CANCER - LONG-TERM RESULTS OF TREATMENT WITH INTENSIVE CISPLATIN-BASED CHEMOTHERAPY OF BRIEF DURATION [J].

HAINSWORTH, JD ;

GROSH, WW ;

BURNETT, LS ;

JONES, HW ;

WOLFF, SN ;

GRECO, FA .

ANNALS OF INTERNAL MEDICINE, 1988, 108 (02) :165-170

[13] INTRAPERITONEAL CISPLATIN WITH SYSTEMIC THIOSULFATE PROTECTION [J].

HOWELL, SB ;

PFEIFLE, CL ;

WUNG, WE ;

OLSHEN, RA ;

LUCAS, WE ;

YON, JL ;

GREEN, M .

ANNALS OF INTERNAL MEDICINE, 1982, 97 (06) :845-851

[14]

HRESHCHYSHYN M M, 1973, Gynecologic Oncology, V1, P220, DOI 10.1016/0090-8258(73)90014-0

[15] HIGH-DOSE CYCLOPHOSPHAMIDE, CARMUSTINE, AND ETOPOSIDE AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR RELAPSED HODGKINS-DISEASE [J].

JAGANNATH, S ;

DICKE, KA ;

ARMITAGE, JO ;

CABANILLAS, FF ;

HORWITZ, LJ ;

VELLEKOOP, L ;

ZANDER, AR ;

SPITZER, G .

ANNALS OF INTERNAL MEDICINE, 1986, 104 (02) :163-168

[16] HIGH-DOSE CISPLATIN COMPARED WITH HIGH-DOSE CYCLOPHOSPHAMIDE IN THE MANAGEMENT OF ADVANCED EPITHELIAL OVARIAN-CANCER (FIGO STAGE-III AND STAGE-IV) - REPORT FROM THE NORTH-THAMES-COOPERATIVE-GROUP [J].

LAMBERT, HE ;

BERRY, RJ .

BRITISH MEDICAL JOURNAL, 1985, 290 (6472) :889-893

[17] DOSE INTENSITY ANALYSIS OF CHEMOTHERAPY REGIMENS IN OVARIAN-CARCINOMA [J].

LEVIN, L ;

HRYNIUK, WM .

JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (05) :756-767

[18]

LIDOR Y, 1989, Proceedings of the American Association for Cancer Research Annual Meeting, V30, P401

[19] COMBINATION INTRAPERITONEAL CHEMOTHERAPY WITH CISPLATIN, CYTARABINE, AND DOXORUBICIN FOR REFRACTORY OVARIAN-CARCINOMA AND OTHER MALIGNANCIES PRINCIPALLY CONFINED TO THE PERITONEAL-CAVITY [J].

MARKMAN, M ;

HOWELL, SB ;

LUCAS, WE ;

PFEIFLE, CE ;

GREEN, MR .

JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (12) :1321-1326

[20]

MCVIE J, 1985, P AM SOC CLIN ONCO C, V485, P125

← 1 2 3 4 →